John Chan, MD is research investigator with the California Pacific Medical Center and Palo Alto Medical Foundation Research Institutes.
Sutter Health Research Enterprise
1100 Van Ness Ave
4th Floor
San Francisco, CA, 94109
(415) 751-1847
John.Chan@sutterhealth.org
Primary Research Interests
Related Clinical Trials
GOG 3086/SUTRO STRO-002-GM3
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer
Investigators: John K Chan MD, Lejla Delic MD
Status: Active, Recruiting
IMGN853-0420
IMGN853 With Carboplatin in Second-line Treatment of FRa Expressing, Platinum-sensitive Epithelial Ovarian Cancer
Investigator: John K Chan MD
Status: Active, Recruiting
Interventional (NRG-GY026)
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Investigator: John K Chan MD
Status: Active, Recruiting
Karyopharm XPORT-EC-042 GOG 3083
Karyopharm XPORT-EC-042 GOG 3083
Investigator: John K Chan MD
Status: Active, Recruiting
Merck MK-2870-005 GOG 3095 (Coming Soon)
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
Investigators: John K Chan MD, Lejla Delic MD